![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MCC |
Gene summary for MCC |
![]() |
Gene information | Species | Human | Gene symbol | MCC | Gene ID | 4163 |
Gene name | MCC regulator of WNT signaling pathway | |
Gene Alias | MCC1 | |
Cytomap | 5q22.2 | |
Gene Type | protein-coding | GO ID | GO:0001667 | UniProtAcc | P23508 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4163 | MCC | CCI_2 | Human | Cervix | CC | 7.98e-16 | 1.53e+00 | 0.5249 |
4163 | MCC | CCI_3 | Human | Cervix | CC | 2.31e-24 | 1.41e+00 | 0.516 |
4163 | MCC | AEH-subject1 | Human | Endometrium | AEH | 3.67e-04 | 1.79e-01 | -0.3059 |
4163 | MCC | AEH-subject2 | Human | Endometrium | AEH | 1.76e-05 | 2.27e-01 | -0.2525 |
4163 | MCC | AEH-subject3 | Human | Endometrium | AEH | 4.52e-06 | 2.26e-01 | -0.2576 |
4163 | MCC | AEH-subject4 | Human | Endometrium | AEH | 9.63e-10 | 4.11e-01 | -0.2657 |
4163 | MCC | AEH-subject5 | Human | Endometrium | AEH | 1.06e-14 | 5.69e-01 | -0.2953 |
4163 | MCC | EEC-subject1 | Human | Endometrium | EEC | 1.11e-43 | 9.49e-01 | -0.2682 |
4163 | MCC | EEC-subject2 | Human | Endometrium | EEC | 1.49e-28 | 7.77e-01 | -0.2607 |
4163 | MCC | EEC-subject3 | Human | Endometrium | EEC | 4.77e-11 | 2.69e-01 | -0.2525 |
4163 | MCC | EEC-subject4 | Human | Endometrium | EEC | 1.21e-13 | 5.20e-01 | -0.2571 |
4163 | MCC | GSM5276934 | Human | Endometrium | EEC | 1.52e-04 | -9.70e-02 | -0.0913 |
4163 | MCC | GSM5276937 | Human | Endometrium | EEC | 5.91e-03 | -1.48e-01 | -0.0897 |
4163 | MCC | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 1.20e-08 | -1.07e-01 | -0.1869 |
4163 | MCC | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 2.33e-07 | -1.20e-01 | -0.1875 |
4163 | MCC | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 8.52e-10 | -9.56e-02 | -0.1883 |
4163 | MCC | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 5.04e-10 | 9.74e-02 | -0.1934 |
4163 | MCC | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 3.89e-10 | -1.69e-01 | -0.1917 |
4163 | MCC | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 5.36e-10 | -1.69e-01 | -0.1916 |
4163 | MCC | GSM6177623_NYU_UCEC3_Vis | Human | Endometrium | EEC | 1.14e-03 | -1.02e-01 | -0.1269 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000915014 | Breast | IDC | purine ribonucleotide metabolic process | 55/1434 | 368/18723 | 1.30e-06 | 5.72e-05 | 55 |
GO:001969314 | Breast | IDC | ribose phosphate metabolic process | 58/1434 | 396/18723 | 1.31e-06 | 5.73e-05 | 58 |
GO:000675313 | Breast | IDC | nucleoside phosphate metabolic process | 68/1434 | 497/18723 | 2.01e-06 | 8.23e-05 | 68 |
GO:000911713 | Breast | IDC | nucleotide metabolic process | 67/1434 | 489/18723 | 2.28e-06 | 9.05e-05 | 67 |
GO:000925914 | Breast | IDC | ribonucleotide metabolic process | 56/1434 | 385/18723 | 2.47e-06 | 9.63e-05 | 56 |
GO:000616314 | Breast | IDC | purine nucleotide metabolic process | 56/1434 | 396/18723 | 5.90e-06 | 1.90e-04 | 56 |
GO:007252114 | Breast | IDC | purine-containing compound metabolic process | 57/1434 | 416/18723 | 1.28e-05 | 3.31e-04 | 57 |
GO:001969324 | Breast | DCIS | ribose phosphate metabolic process | 58/1390 | 396/18723 | 4.80e-07 | 2.11e-05 | 58 |
GO:000915024 | Breast | DCIS | purine ribonucleotide metabolic process | 55/1390 | 368/18723 | 4.92e-07 | 2.14e-05 | 55 |
GO:000925924 | Breast | DCIS | ribonucleotide metabolic process | 56/1390 | 385/18723 | 9.44e-07 | 3.79e-05 | 56 |
GO:000616324 | Breast | DCIS | purine nucleotide metabolic process | 56/1390 | 396/18723 | 2.31e-06 | 8.29e-05 | 56 |
GO:000911723 | Breast | DCIS | nucleotide metabolic process | 65/1390 | 489/18723 | 3.19e-06 | 1.03e-04 | 65 |
GO:007252124 | Breast | DCIS | purine-containing compound metabolic process | 57/1390 | 416/18723 | 5.07e-06 | 1.48e-04 | 57 |
GO:000675323 | Breast | DCIS | nucleoside phosphate metabolic process | 65/1390 | 497/18723 | 5.51e-06 | 1.59e-04 | 65 |
GO:009013210 | Cervix | CC | epithelium migration | 90/2311 | 360/18723 | 2.45e-11 | 6.11e-09 | 90 |
GO:00016679 | Cervix | CC | ameboidal-type cell migration | 110/2311 | 475/18723 | 2.66e-11 | 6.36e-09 | 110 |
GO:001063110 | Cervix | CC | epithelial cell migration | 89/2311 | 357/18723 | 3.72e-11 | 8.54e-09 | 89 |
GO:009013010 | Cervix | CC | tissue migration | 90/2311 | 365/18723 | 5.42e-11 | 1.05e-08 | 90 |
GO:00506737 | Cervix | CC | epithelial cell proliferation | 98/2311 | 437/18723 | 2.01e-09 | 2.15e-07 | 98 |
GO:001063210 | Cervix | CC | regulation of epithelial cell migration | 72/2311 | 292/18723 | 4.52e-09 | 4.43e-07 | 72 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MCC | SNV | Missense_Mutation | novel | c.2517N>T | p.Lys839Asn | p.K839N | P23508 | protein_coding | deleterious(0.02) | probably_damaging(0.985) | TCGA-CN-5360-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | SD |
MCC | SNV | Missense_Mutation | novel | c.1759N>A | p.Glu587Lys | p.E587K | P23508 | protein_coding | deleterious(0.01) | probably_damaging(0.953) | TCGA-CV-7427-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
MCC | SNV | Missense_Mutation | rs149948216 | c.2756N>A | p.Arg919Gln | p.R919Q | P23508 | protein_coding | deleterious(0.01) | probably_damaging(0.947) | TCGA-D6-A6EN-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
MCC | SNV | Missense_Mutation | rs775881721 | c.706N>T | p.Arg236Trp | p.R236W | P23508 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-UF-A719-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
MCC | SNV | Missense_Mutation | rs200082888 | c.832G>A | p.Val278Ile | p.V278I | P23508 | protein_coding | tolerated(0.63) | benign(0.001) | TCGA-EJ-5501-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD |
MCC | SNV | Missense_Mutation | c.1652N>G | p.Ala551Gly | p.A551G | P23508 | protein_coding | deleterious(0.01) | probably_damaging(0.98) | TCGA-EJ-5504-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 7 | Unknown | Unknown | SD | |
MCC | SNV | Missense_Mutation | rs749827179 | c.1343N>A | p.Arg448Gln | p.R448Q | P23508 | protein_coding | tolerated(0.07) | probably_damaging(0.964) | TCGA-YL-A8SJ-01 | Prostate | prostate adenocarcinoma | Male | <65 | 9 | Unknown | Unknown | PD |
MCC | SNV | Missense_Mutation | c.2740N>G | p.Thr914Ala | p.T914A | P23508 | protein_coding | tolerated(1) | benign(0) | TCGA-BR-4362-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MCC | SNV | Missense_Mutation | c.1802N>G | p.Lys601Arg | p.K601R | P23508 | protein_coding | tolerated(0.58) | probably_damaging(0.969) | TCGA-BR-6452-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MCC | SNV | Missense_Mutation | novel | c.712N>G | p.Leu238Val | p.L238V | P23508 | protein_coding | tolerated(0.95) | benign(0.117) | TCGA-BR-7704-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |